期刊文献+

负载双片段survivin短发夹状RNA质粒载体的构建与鉴定 被引量:2

Construction and Identification of Plasmid Vector Encoding Two Survivin ShRNA
在线阅读 下载PDF
导出
摘要 目的:设计构建负载双片段survivin短发夹状RNA(shRNA)的质粒载体,为进行前列腺癌(PCa)基因治疗的研究奠定基础。方法:分别设计2条靶向survivin基因的shRNA,克隆至质粒载体中,再分别提取质粒酶切后回收、连接,构建重组质粒,提取重组质粒酶切鉴定、测序分析。结果:负载不同单片段survivinshRNA的质粒载体分别用EcoRⅠ及SacⅠ酶切鉴定,证实设计的2条单片段survivinshRNA已经分别插入目的质粒中;基因重组后,重组质粒载体用BamHⅠ酶切鉴定,证实双片段survivinshRNA均已插入重组质粒载体中;测序结果证实重组质粒载体插入的双片段survivinshRNA序列均正确无误。结论:负载双片段survivinshRNA的RNA干扰重组质粒载体构建成功。 Objective: To construct and identify the eukaryotic expression plasmids encoding two short hairpin RNA (shRNA) of survivin for the purpose of paving the way for the studies of targeted gene therapy for prostatic carcinoma(PCa). Methods; Two shRNA of survivin were designed and synthesized respectively, and then both were cloned into plasmids. Finally, the recombinant plasmids were confirmed by sequencing and agarose gel electrophoresis after restriction digestion. Results: The recombinant plasmids encoding two survivin shRNA were constructed and the aim sequence obtained. Conclusion: Successful construction of the recombinant pro- vides a sound basis for the research of targeted gene therapy for PCa.
出处 《中华男科学杂志》 CAS CSCD 2006年第6期512-515,共4页 National Journal of Andrology
基金 江苏省高校自然科学基金(04KJB320128)
关键词 前列腺肿瘤 SURVIVIN RNA干扰 短发夹状RNA 载体构建 prostatic neoplasm survivin RNA interference short hairpin RNA vector construction
作者简介 杨光天(1972-),男,江苏连云港市人,主治医师,硕士,从事泌尿外科及男科学专业。现在连云港市第一人民医院泌尿外科工作。通讯作者:单玉喜,E-mail:shyx-1002@163.com
  • 相关文献

参考文献7

  • 1Kaur P,Kallakury BS,Sheehan CE,et al.Survivin and Bcl-2 expression in prostatic adenocarcinomas[J].Arch Pathol Lab Med,2004,128(1):39-43.
  • 2Pennati M,Binda M,Colella G,et al.Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells[J].Oncogene,2004,23(2):386-394.
  • 3高丽芳,徐德启,邵月婷,赵丹,赵雪俭.RNA干扰技术沉默STAT3对人前列腺癌细胞生长的抑制作用[J].中华男科学杂志,2005,11(1):29-33. 被引量:17
  • 4Tuschl T.Expanding small RNA interference[J].Nat Biotechnol,2002,20(5):446-448.
  • 5Fortugno P,Wall NR,Giodini A,et al.Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function[J].J Cell Sci,2002,115(3):575-585.
  • 6郑华川,陈颖,况立革,杨琳,李锦毅,吴东瑛,张素敏,辛彦.PTEN编码产物在胃癌发生发展不同阶段中的表达及意义[J].中华肿瘤杂志,2003,25(1):13-16. 被引量:68
  • 7HannonGJ.RNA interference[J].Nature,2002,418(6894):244-251.

二级参考文献14

  • 1Yan Xin,Xiao Ling Li,Yan Ping Wang,Su Min Zhang,Hua Chuan Zheng,Dong Ying Wu,Yin Chang Zhang The Fourth Laboratory of Cancer Institute, China Medical University, Shenyang 110001, Liaoning Province, China.Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas[J].World Journal of Gastroenterology,2001,7(1):53-59. 被引量:39
  • 2Weiss JM, Nath A, Major EO, et al. HIV-1 Tat induces monocyte chemoattractant protein-l-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes[ J]. J Immunol, 1999,163 ( 5 ) :2953-2959.
  • 3Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis[J]. Oncogene, 2000, 19(21) :2474-2488.
  • 4Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of STAT3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo [ J ]. Proc Natl Acad Sci USA, 2000, 97 (8):4227 -4232.
  • 5Schuringa JJ, Wierenga AT, Knfijer W, et al. Constitutive STAT3,Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6 [ J ].Blood, 2000, 95(12) :3765-3770.
  • 6Badache A, Hynes NE. Interleukin 6 inhibits proliferation and,in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells [ J ]. CancerRes, 2001,61 ( 1 ) :383-391.
  • 7Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention[J]. Clin Cancer Res, 2002, 8(4) :945-954.
  • 8Bromberg JF, Horvath CM, Besser D, et al. STAT3 activation is required for cellular transformation by v-src [ J ]. Mol Cell Biol,1998, 18(5) :2553-2558.
  • 9Leong PL, Andrews GA, Johnson DE, et al. Targeted inhibition of STAT3 with a decoy oligonucleotide abrogates head and neck cancer cell growth[J]. Proc Natl Acad Sci USA, 2003,100(7) :4138-4143.
  • 10Huang JS, Guh JY, Hung WC, et al. Role of the Janus kinase(JAK)/signal transducers and activators of transcription (STAT)cascade in advanced glycation end-product-induced cellular mitogenesisNRK-49F cells [J]. Biochem J, 1999, 342( pt 1 ) :231-238.

共引文献83

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部